Editor
Jesper Bo Nielsen
Department of Public Health, University of Southern Denmark, Denmark
Editor Information
| Name | Jesper Bo Nielsen |
|---|---|
| Role | Editor |
| Institution | University of Southern Denmark |
| Department | Department of Public Health |
| Country | Denmark |
| ORCID | 0000 0002 5764 5462 |
Biography
Jesper
Bo Nielsen (JBN) has for the last 14 years chaired the Institute of Public
Health. JBN has now the overall responsibility for staff (>250 employees),
economy (annual turnaround >130 million Kroner), research (8 research units
plus a few research centers), teaching (3 educations with main responsibility
besides participation in 5-6 other educations), and administration. During JBNs
time in office, the Institute has received more than 850 million Kroner in
external research grants, and strategic collaborations with neighbor institutions
have been strengthened through affiliation agreements. During the leadership of
JBN, the first Max Planck Center in the Nordic Countries was opened in 2013 and
affiliated to the Institute.
Over
the recent years,
Jesper
Bo Nielsen
has attracted substantial funding and initiated
independent research projects within areas such as dermal absorption, medical risk
analysis, risk communication, medical decision making, and development and use
of decision aids. The latter four themes related to the interaction between
citizen, patient and health care professionals with a focus on risk behavior,
communication, barriers and incitements, and decision aids.
Bo Nielsen (JBN) has for the last 14 years chaired the Institute of Public
Health. JBN has now the overall responsibility for staff (>250 employees),
economy (annual turnaround >130 million Kroner), research (8 research units
plus a few research centers), teaching (3 educations with main responsibility
besides participation in 5-6 other educations), and administration. During JBNs
time in office, the Institute has received more than 850 million Kroner in
external research grants, and strategic collaborations with neighbor institutions
have been strengthened through affiliation agreements. During the leadership of
JBN, the first Max Planck Center in the Nordic Countries was opened in 2013 and
affiliated to the Institute.
Over
the recent years,
Jesper
Bo Nielsen
has attracted substantial funding and initiated
independent research projects within areas such as dermal absorption, medical risk
analysis, risk communication, medical decision making, and development and use
of decision aids. The latter four themes related to the interaction between
citizen, patient and health care professionals with a focus on risk behavior,
communication, barriers and incitements, and decision aids.